OncoGen.AI: an integrated platform for automated genomic analysis and reporting in precision oncology

This cohort/real-world study was triaged for T5 - Precision Oncology/Genomic Medicine based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

This cohort/real-world study was triaged for T5 - Precision Oncology/Genomic Medicine based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

What the study was

Study design

Cohort/real-world study

Maturity

Validated

Journal

NPJ precision oncology

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.